SWK Holdings
  • Home
  • About SWK
    • People
    • Board of Directors
  • Our Approach
    • Investment Process
    • Investment Criteria
    • Creative Capital Solutions
    • Partner with SWK
  • Portfolio
  • Investor Relations
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources
    • Enteris Biopharma
  • Enteris Biopharma
  • Contact Us
Select Page

SWK Holdings Elects CEO Winston Black as New Chairman of the Board

by winston | Nov 21, 2019 | 2019, News

Board Realignment Follows SWK’s Acquisition of Enteris BioPharma Dallas, TX, November 21, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that Winston Black, Chief Executive Officer...

SWK Holdings Corporation Announces 2019 Third Quarter Financial Results

by winston | Nov 18, 2019 | 2019, News

Corporate HighlightsAcquired Enteris BioPharma, Inc. (“Enteris”) a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence®Enteris to operate as an independent, wholly-owned subsidiary of...

SWK Holdings to Present at the Fall Investor Summit

by winston | Sep 16, 2019 | 2019, News, Uncategorized

SWK Holdings to Present at the Fall Investor Summit Presentation Scheduled for Today, September 16, 2019, at 4:30 p.m., ET Dallas, TX, September 16, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company,...

SWK Holdings Corporation Resumes Share Repurchase Program

by winston | Sep 6, 2019 | 2019, News, Uncategorized

Dallas, TX, September 6, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of...

SWK Holdings Corporation Files Application for Uplisting to NASDAQ Capital Market

by winston | Sep 3, 2019 | 2019, News

SWK Expands Board of Directors to Meet NASDAQ Listing RequirementsDallas, TX – September 3, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that the Company has submitted its formal...
« Older Entries

Year

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

© 2019 SWK Holdings. All Rights Reserved.

SWK Holdings Corporation

14755 Preston Road, Suite 105
Dallas, TX 75254
Phone: 972.687.7250
Fax: 972.687.7255

For Investors:
investorrelations@swkhold.com

For Capital Alternatives:
inquiries@swkhold.com

For Career Opportunities:
recruiting@swkhold.com